James E. Audia
Direktor/Vorstandsmitglied bei Ribon Therapeutics, Inc.
Aktive Positionen von James E. Audia
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Direktor/Vorstandsmitglied | 01.04.2018 | - |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is a non-profit organization based in Chicago, IL and has subsidiaries in the United States. The non-profit company provides information and resources for Alzheimer's and other dementias. Joanne Pike has been the CEO of the company since 2021. | Corporate Officer/Principal | 01.01.2020 | - |
Karriereverlauf von James E. Audia
Ehemalige bekannte Positionen von James E. Audia
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KARA THER | Corporate Officer/Principal | 01.11.2019 | 18.03.2024 |
CONSTELLATION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.07.2017 | 15.07.2021 |
Technik-/Wissenschafts-/F&E-Leiter | 05.01.2011 | 01.07.2017 | |
Independent Dir/Board Member | 01.07.2017 | 15.07.2021 | |
Chicago Biomedical Consortium | Direktor/Vorstandsmitglied | 01.08.2017 | 01.10.2019 |
Ausbildung von James E. Audia
University of South Carolina | Doctorate Degree |
Yale University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 3 |
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Chicago Biomedical Consortium | |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Health Technology |
Alzheimer’s Association
Alzheimer’s Association Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association is a non-profit organization based in Chicago, IL and has subsidiaries in the United States. The non-profit company provides information and resources for Alzheimer's and other dementias. Joanne Pike has been the CEO of the company since 2021. | Commercial Services |
Karuna Therapeutics, Inc.
Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- James E. Audia
- Erfahrung